[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2539126B1 - Derives amino-alcoyl-sulfoniques, leur procede de preparation, et compositions pharmaceutiques en renfermant - Google Patents

Derives amino-alcoyl-sulfoniques, leur procede de preparation, et compositions pharmaceutiques en renfermant

Info

Publication number
FR2539126B1
FR2539126B1 FR8400112A FR8400112A FR2539126B1 FR 2539126 B1 FR2539126 B1 FR 2539126B1 FR 8400112 A FR8400112 A FR 8400112A FR 8400112 A FR8400112 A FR 8400112A FR 2539126 B1 FR2539126 B1 FR 2539126B1
Authority
FR
France
Prior art keywords
alcoyl
amino
preparation
pharmaceutical compositions
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8400112A
Other languages
English (en)
Other versions
FR2539126A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BONONI LORIS
Original Assignee
BONONI LORIS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BONONI LORIS filed Critical BONONI LORIS
Publication of FR2539126A1 publication Critical patent/FR2539126A1/fr
Application granted granted Critical
Publication of FR2539126B1 publication Critical patent/FR2539126B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8400112A 1983-01-07 1984-01-05 Derives amino-alcoyl-sulfoniques, leur procede de preparation, et compositions pharmaceutiques en renfermant Expired FR2539126B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19027/83A IT1193590B (it) 1983-01-07 1983-01-07 Derivati amino-alchil-solfonici,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono

Publications (2)

Publication Number Publication Date
FR2539126A1 FR2539126A1 (fr) 1984-07-13
FR2539126B1 true FR2539126B1 (fr) 1986-04-04

Family

ID=11153941

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8400112A Expired FR2539126B1 (fr) 1983-01-07 1984-01-05 Derives amino-alcoyl-sulfoniques, leur procede de preparation, et compositions pharmaceutiques en renfermant

Country Status (7)

Country Link
US (1) US4472402A (fr)
EP (1) EP0115657B1 (fr)
JP (1) JPS59155370A (fr)
BE (1) BE898610A (fr)
DE (1) DE3378315D1 (fr)
FR (1) FR2539126B1 (fr)
IT (1) IT1193590B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124333A (en) * 1989-08-02 1992-06-23 Ube Industries, Ltd. Aminopyrimidine derivatives and harmful organisms preventive agent
EP1609467A1 (fr) * 1998-07-28 2005-12-28 Neurochem (International) Limited Compositions pour le traitement des maladies associées aux interactions moleculaires des glycosaminoglycanes
US6310073B1 (en) 1998-07-28 2001-10-30 Queen's University At Kingston Methods and compositions to treat glycosaminoglycan-associated molecular interactions
US6562836B1 (en) 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
US7244764B2 (en) 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US7414076B2 (en) 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
AU2005326962A1 (en) 2004-12-22 2006-08-17 Bellus Health (International) Limited Methods and compositions for treating amyloid-related diseases
BRPI0717794B8 (pt) 2006-10-12 2021-05-25 Bellus Health International Ltd composto e composição farmacêutica de ácido 3-amino-1-propanosulfônico

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1055560B (it) * 1974-05-02 1982-01-11 Istituto Chemioterapico Derivati pirimidinici e relative composizioni per il trattamento di infezioni virali
DE2920949A1 (de) * 1979-05-23 1980-11-27 Bayer Ag Reaktivfarbstoffe
JPS5679674A (en) * 1979-12-03 1981-06-30 Mitsui Petrochem Ind Ltd Preparation of amino group-containing pyrimidine derivative
JPS57126481A (en) * 1981-01-29 1982-08-06 Sankyo Co Ltd Aminopyrimidine derivative, fungicide, insecticide, and acaricide
JPS57176967A (en) * 1981-04-21 1982-10-30 Sankyo Co Ltd Aminopyrimidine derivative and antibacterial, insecticidal and miticidal agent
JPS5852276A (ja) * 1981-09-22 1983-03-28 Mitsui Petrochem Ind Ltd ４−アミノ−２−ハロゲノピリミジン誘導体の製造方法
JPS5936666A (ja) * 1982-07-23 1984-02-28 Sankyo Co Ltd アミノピリミジン誘導体

Also Published As

Publication number Publication date
FR2539126A1 (fr) 1984-07-13
EP0115657B1 (fr) 1988-10-26
IT1193590B (it) 1988-07-08
BE898610A (fr) 1984-05-02
IT8319027A0 (it) 1983-01-07
EP0115657A1 (fr) 1984-08-15
DE3378315D1 (en) 1988-12-01
JPS59155370A (ja) 1984-09-04
US4472402A (en) 1984-09-18

Similar Documents

Publication Publication Date Title
PT77488A (fr) Procede de preparation de derives de phenyl-1-piperidino-2-propanol et de compositions pharmaceutiques les contenant
FR2514769B1 (fr) Dipropionate de beclomethasone, son procede de preparation et compositions pharmaceutiques le contenant
DE3068020D1 (en) Aminoalkylbenzene derivatives, process for their preparation and pharmaceutical compositions
DE3366393D1 (en) Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same
FR2542740B1 (fr) Derives de thiazolidine, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2532648B1 (fr) Derives de carbostyrile, leur procede de preparation et leur application en therapeutique
BE885385A (fr) Derives de d-6-n-propylergolines, leur procede de preparation et compositions pharmaceutiques en contenant
FR2680506B1 (fr) Procede de preparation de derives de la beta-phenylisoserine et leur utilisation.
DE3062884D1 (en) Spiro-hydantoin derivatives, process for their preparation and pharmaceutical compositions thereof
FR2539126B1 (fr) Derives amino-alcoyl-sulfoniques, leur procede de preparation, et compositions pharmaceutiques en renfermant
FR2531708B1 (fr) Derives de la xanthine, leur procede de preparation et compositions pharmaceutiques les contenant
FR2669633B1 (fr) Nouveaux derives de la benzoselenazolinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
IL62747A (en) 2-guanidinothiazole derivatives,process for the preparation thereof and pharmaceutical compositions comprising the same
MA19907A1 (fr) Procede de preparation de derives de la thiatriazine et utilisation de ceux-ci dans des compositions pharmaceutiques.
BE890874A (fr) Derives de la pyrimidine, leur procede de preparation et les compositions pharmaceutiques les contenant
PT77751B (fr) Procede de preparation de derives benzylideniques soufres et de compositions pharmaceutiques le contenant
MA19893A1 (fr) Procede de preparation de derives de sulfamoylbenzophenone et utilisation de ceux-ci dans des compositions pharmaceutiques.
FR2551440B1 (fr) Aminocyclopentanes, leur procede de preparation et compositions pharmaceutiques les contenant
DE3267034D1 (en) Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same
FR2649981B1 (fr) Derives de dihydropyrimidothiazine, leur procede de preparation et compositions pharmaceutiques les contenant
FR2529551B1 (fr) Derives d'eburnane-oxime, procede pour leur preparation et compositions pharmaceutiques contenant ces composes
BE871824A (fr) Nouveaux derives steroides 17 alpha-aryle, leur procede de preparation et les compositions pharmaceutiques les renfermant
FR2617164B1 (fr) Nouveaux derives de la decahydroquinoleine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
BE893057A (fr) Derives de beta-lactame, les compositions pharmaceutiques les contenant et leur procede de preparation
BE889340A (fr) Derives de 1,6-naphtyridine, procede pour leur preparation et compositions pharmaceutiques et agrochimiques qui les contiennent

Legal Events

Date Code Title Description
ST Notification of lapse